The landmark clinical results in the dental indication have generated serious interest from major companies. Clinical results showing significant benefit in orthopaedic indications are coming out soon, and significant interest from companies in the orthopaedic field is expected. AddBIO is pursuing a co-development and collaboration agreement with dental and orthopaedic implant partners. Zolidd is well suited for application to the implant of leading implant companies, who could benefit from differentiation and true clinical improvements.
- Bli medlem
- Om SwedenBIO